1.Function Positioning and Implementation Path of Internal Control in Public Hospitals from the Perspective of Finan-cial and Accounting Supervision
Hua FU ; Xiaozhe DAI ; Daxi ZHENG ; Yi WANG ; Dengjiao DONG ; Liyan WANG ; Changrong ZHOU ; Haifen SUN ; Jinxiu SHI
Chinese Health Economics 2024;43(1):82-85,88
With the reform of the medical and health system entering a critical period,public hospitals have also exposed new risks and challenges in economic operation.As an important means of hospital standardized management,internal control can better prevent and resolve the risk of hospital economic operation and ensure the sustainable operation of the hospital.By interpreting the requirements of current national policies on hospital internal control,it analyzes the functional positioning of financial and accounting supervision in hospital internal control,shares the internal control implementation path of sample hospitals from the perspective of financial and accounting supervision,and puts forward suggestions on strengthening internal control construction of public hospitals in the new era,in order to lay a good foundation for the high-quality development of hospitals.
2.Management of surplus drugs from the perspective of financial and accounting supervision in a large public hospital
Yongheng LEI ; Danni WEN ; Xiaozhe DAI
Chinese Journal of Hospital Administration 2024;40(6):454-457
Surplus drugs are commonly found in hospitals at all levels, which is a difficult point in drug management and carries compliance risks. In order to standardize the management of surplus drugs and improve the efficiency of medical resource utilization, a large tertiary hospital launched a practice of surplus drug management from the perspective of financial and accounting supervision in May 2023. This practice conducted a risk analysis of the entire process of surplus drug circulation, combined with the requirements of internal control construction in public hospitals, and explored in depth from five aspects: institutionalization of surplus drug financial management, institutionalization of process flow, standardization of process forms, informatization of forms, and information disclosure. It initially achieved full process control of surplus drug sources, circulation control, complete recording, and accurate accounting, effectively preventing potential risks in surplus drug management, so as to provide references for other hospitals to strengthen internal control management of surplus drugs.
3.Current situation and countermeasures for the management of surplus drugs in medical institutions of China
Guangjie WU ; Wei FU ; Lin QIU ; Dongyan LI ; Fanxue XIN ; Jianling ZHENG ; Xiaozhe DAI ; Qian CHEN ; Yan LIU ; Li TAN ; Dong LIU ; Juan LI
Chinese Journal of Hospital Administration 2024;40(6):444-447
The management of surplus drugs is an important part of drug administration. At present, China′s medical institutions are in the initial exploration stage in managing surplus drugs.This study analyzed the causes, safety hazards, management policies, and management problems of surplus drugs in medical institutions, and proposed targeted countermeasures and suggestions, including establishing unified and standardized management methods, consensus or guidelines, optimizing internal management of medical institutions, improving the management awareness of medical staff, and clarifying the benefits of surplus drugs, so as to provide references for medical institutions to manage surplus drugs reasonably.
4.Management of surplus drugs in a large tertiary hospital
Dongyan LI ; Wei FU ; Lin QIU ; Guangjie WU ; Fanxue XIN ; Jianling ZHENG ; Xiaozhe DAI ; Qian CHEN ; Yan LIU ; Li TAN ; Dong LIU ; Juan LI
Chinese Journal of Hospital Administration 2024;40(6):448-453
To standardize the management of surplus drugs, improve the efficiency of medical resource utilization, promote the rational use of medical insurance funds, and reduce the financial burden on patients, a large tertiary hospital implemented a practice for managing surplus drugs starting in May 2023. This practice encompassed multiple aspects, including the establishment of organizational structure, clarification of responsibilities, formulation of billing for fractional doses and a reasonable surplus drugs list, establishment of standardized management processes, and allocation of special funds for surplus drugs. These efforts had initially achieved effective management of surplus drugs. As of November 2023, the management of surplus drugs had benefited 136 908 patients, with an average savings of 873.61 yuan per patient and a cumulative savings of approximately 34.7 million yuan in medical insurance funds. This practice had effectively reduced the wastage of medical resources, and could provide references for promoting standardized management of surplus drugs in medical institutions of China. In the future, the hospital should further expand the coverage of surplus drugs, ensure patients′ rights to informed consent, and establish a comprehensive performance incentive mechanism to promote the sustainable development of surplus drug management.